Mesa Laboratories, Inc. (MLAB)

US — Technology Sector
Peers: NOVT  ITRI  FTV  VPG  COHR  ESE  ST  SEPJF  FCUV  BMI  VNT 

Automate Your Wheel Strategy on MLAB

With Tiblio's Option Bot, you can configure your own wheel strategy including MLAB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MLAB
  • Rev/Share 43.792
  • Book/Share 28.5898
  • PB 3.9595
  • Debt/Equity 1.3634
  • CurrentRatio 0.7111
  • ROIC 0.0438

 

  • MktCap 615084652.0
  • FreeCF/Share 7.9202
  • PFCF 14.3046
  • PE -2.4637
  • Debt/Assets 0.4841
  • DivYield 0.0057
  • ROE -1.6283

 

  • Rating
  • Score
  • Recommendation
  • P/E Score
  • DCF Score
  • P/B Score
  • D/E Score

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation MLAB Wells Fargo -- Underweight -- $120 Aug. 28, 2024

News

Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
MLAB
Published: May 28, 2025 by: Zacks Investment Research
Sentiment: Negative

Mesa Labs (MLAB) came out with quarterly earnings of $2.23 per share, missing the Zacks Consensus Estimate of $2.75 per share. This compares to earnings of $2.77 per share a year ago.

Read More
image for news Mesa Labs (MLAB) Q4 Earnings and Revenues Lag Estimates
MESA LABS DECLARES QUARTERLY DIVIDEND
MLAB
Published: April 07, 2025 by: GlobeNewsWire
Sentiment: Neutral

LAKEWOOD, Colo., April 07, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.

Read More
image for news MESA LABS DECLARES QUARTERLY DIVIDEND
What Makes Mesa Labs (MLAB) a New Strong Buy Stock
MLAB
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive

Mesa Labs (MLAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Read More
image for news What Makes Mesa Labs (MLAB) a New Strong Buy Stock
Why Mesa Labs (MLAB) Might be Well Poised for a Surge
MLAB
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Positive

Mesa Labs (MLAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Read More
image for news Why Mesa Labs (MLAB) Might be Well Poised for a Surge

About Mesa Laboratories, Inc. (MLAB)

  • IPO Date 1984-02-29
  • Website https://www.mesalabs.com
  • Industry Hardware, Equipment & Parts
  • CEO Mr. Gary M. Owens
  • Employees 736
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.